L Vignolo

Adding low‐dose gemtuzumab ozogamicin to fludarabine, Ara‐C and idarubicin (MY‐FLAI) may improve disease‐free and overall survival in elderly patients with non‐M3 acute myeloid leukaemia: results of a prospective, pilot, multi‐centre trial and comparison with a historical cohort of patients

Marino Clavio, L Vignolo, Alessandra Albarello et al. · British Journal of Haematology · 2007 · 42 citations

Medicine, Hematology, Pharmacology +15

WT1 overexpression at diagnosis may predict favorable outcome in patients with<i>de novo</i>non-M3 acute myeloid leukemia

Maurizio Miglino, Nicoletta Colombo, Gian-Matteo Pica et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 37 citations

Medicine, Hematology, Oncology +16

Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes

Enrico Balleari, Marino Clavio, Eleonora Arboscello et al. · Leukemia Research · 2011 · 19 citations

Medicine, Hematology, Internal Medicine +5

Providing a nurse-led complex nursing INtervention FOcused on quality of life assessment on advanced cancer patients: The INFO-QoL pilot trial

Gianluca Catania, Milko Zanini, Alessio Signori et al. · European Journal of Oncology Nursing · 2021 · 13 citations · Full text

Medicine, Oncology, Oncology Nursing +14

Disaccharidase activities of duodenal mucosa in children. (Normal subjects, coeliac DISEASE, malnutrition, cystic fibrosis of pancreas, other chronic enteropathies).

S Nordio, Lamedica Gm, A Berio et al. · PubMed · 1966 · 10 citations

Medicine, Biochemistry, Pediatrics +12